Displaying 25 - 36 of 36

Display:

12 24 48

Metabolism, Alcohol & Toxicity

3

Novo Nordisk: Navigating MASH patient care - EASL Congress 2024

View

Metabolism, Alcohol & Toxicity

5

Novo Nordisk: Unfolding the metabolic dysfunction of MASH: exploring the pathophysiology and outcomes - EASL Congress 2024

View

Metabolism, Alcohol & Toxicity

5

Novo Nordisk: Unfolding the metabolic dysfunction of MASH: exploring the pathophysiology and outcomes - EASL Congress 2024

View

Metabolism, Alcohol & Toxicity

5

Novo Nordisk: Unfolding the metabolic dysfunction of MASH: exploring the pathophysiology and outcomes - EASL Congress 2024

View

Metabolism, Alcohol & Toxicity

5

Novo Nordisk: Unfolding the metabolic dysfunction of MASH: exploring the pathophysiology and outcomes - EASL Congress 2024

View

Metabolism, Alcohol & Toxicity

5

Novo Nordisk: Unfolding the metabolic dysfunction of MASH: exploring the pathophysiology and outcomes - EASL Congress 2024

View

Metabolism, Alcohol & Toxicity

6

Novo Nordisk:Clinical harmonisation for improving NASH diagnosis - NAFLD Summit 2022

View

Metabolism, Alcohol & Toxicity

6

Novo Nordisk:Clinical harmonisation for improving NASH diagnosis - NAFLD Summit 2022

View

Metabolism, Alcohol & Toxicity

6

Novo Nordisk:Clinical harmonisation for improving NASH diagnosis - NAFLD Summit 2022

View

Metabolism, Alcohol & Toxicity

6

Novo Nordisk:Clinical harmonisation for improving NASH diagnosis - NAFLD Summit 2022

View

Metabolism, Alcohol & Toxicity

6

Novo Nordisk:Clinical harmonisation for improving NASH diagnosis - NAFLD Summit 2022

View

Metabolism, Alcohol & Toxicity

6

Novo Nordisk:Clinical harmonisation for improving NASH diagnosis - NAFLD Summit 2022

View

Displaying 25 - 36 of 36

Display:

12 24 48